CA2326388C - Polypeptide comprenant l'acide amine d'un produit tronque de la proteine a n-terminale fixant la choline, vaccin derive de ce polypeptide et ses utilisations - Google Patents

Polypeptide comprenant l'acide amine d'un produit tronque de la proteine a n-terminale fixant la choline, vaccin derive de ce polypeptide et ses utilisations Download PDF

Info

Publication number
CA2326388C
CA2326388C CA2326388A CA2326388A CA2326388C CA 2326388 C CA2326388 C CA 2326388C CA 2326388 A CA2326388 A CA 2326388A CA 2326388 A CA2326388 A CA 2326388A CA 2326388 C CA2326388 C CA 2326388C
Authority
CA
Canada
Prior art keywords
polypeptide
lys
glu
ala
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA2326388A
Other languages
English (en)
Other versions
CA2326388A1 (fr
Inventor
Elaine I. Tuomanen
H. Robert Masure
Theresa M. Wizemann
Leslie Sydnor Johnson
Scott Koenig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
St Jude Childrens Research Hospital
MedImmune LLC
Original Assignee
St Jude Childrens Research Hospital
MedImmune LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/056,019 external-priority patent/US6858706B2/en
Application filed by St Jude Childrens Research Hospital, MedImmune LLC filed Critical St Jude Childrens Research Hospital
Publication of CA2326388A1 publication Critical patent/CA2326388A1/fr
Application granted granted Critical
Publication of CA2326388C publication Critical patent/CA2326388C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C07K14/3156—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci from Streptococcus pneumoniae (Pneumococcus)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pulmonology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un polypeptide isolé comprenant une séquence d'acides aminés d'un produit tronqué de la protéine A N-terminale fixant la choline, laquelle séquence apparaît dans SEQ ID NOS: 1, 3-7 ou 9-11, y compris les fragments, mutants, variants, analogues ou dérivés de ce polypeptide. L'invention concerne également un polypeptide isolé comprenant une séquence d'acides aminés d'un produit tronqué de la protéine A N-terminale fixant la choline, où l'acide aminé apparaît dans SEQ ID NO 2, où le polypeptide conserve sa structure tertiaire d'origine. L'invention concerne également les méthodes d'élaboration de ce polypeptide. L'invention concerne également un polypeptide isolé comprenant une séquence d'acides aminés d'un produit tronqué de la protéine A N-terminale fixant la choline, où le polypeptide présente une activité de lectine et ne fixe pas la choline. L'invention concerne également un polypeptide isolé immunogène comprenant une séquence d'acides aminés d'un produit tronqué de la protéine A N-terminale fixant la choline. L'invention concerne également un acide nucléique isolé codant un polypeptide comprenant une séquence d'acides aminés d'un produit tronqué de la protéine A N-terminale fixant la choline. Enfin, l'invention concerne des compositions pharmaceutiques, des vaccins et des méthodes diagnostiques et thérapeutiques d'utilisation de ces compositions et de ces vaccins.
CA2326388A 1998-04-07 1999-04-07 Polypeptide comprenant l'acide amine d'un produit tronque de la proteine a n-terminale fixant la choline, vaccin derive de ce polypeptide et ses utilisations Expired - Fee Related CA2326388C (fr)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US8087898P 1998-04-07 1998-04-07
US09/056,019 1998-04-07
US60/080,878 1998-04-07
US09/056,019 US6858706B2 (en) 1998-04-07 1998-04-07 Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
PCT/US1999/007669 WO1999051188A2 (fr) 1998-04-07 1999-04-07 Polypeptide comprenant l'acide amine d'un produit tronque de la proteine a n-terminale fixant la choline, vaccin derive de ce polypeptide et ses utilisations

Publications (2)

Publication Number Publication Date
CA2326388A1 CA2326388A1 (fr) 1999-10-14
CA2326388C true CA2326388C (fr) 2014-02-04

Family

ID=26734874

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2326388A Expired - Fee Related CA2326388C (fr) 1998-04-07 1999-04-07 Polypeptide comprenant l'acide amine d'un produit tronque de la proteine a n-terminale fixant la choline, vaccin derive de ce polypeptide et ses utilisations

Country Status (14)

Country Link
JP (1) JP4739521B2 (fr)
KR (1) KR100638503B1 (fr)
CN (1) CN1191851C (fr)
AU (2) AU764811B2 (fr)
BR (1) BR9909910A (fr)
CA (1) CA2326388C (fr)
HU (1) HUP0102306A3 (fr)
IL (1) IL138939A0 (fr)
MX (1) MXPA00009899A (fr)
NO (1) NO20005081L (fr)
NZ (1) NZ507983A (fr)
PL (1) PL193132B1 (fr)
TR (1) TR200003498T2 (fr)
WO (1) WO1999051188A2 (fr)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0022742D0 (en) 2000-09-15 2000-11-01 Smithkline Beecham Biolog Vaccine
TWI457133B (zh) 2005-12-13 2014-10-21 Glaxosmithkline Biolog Sa 新穎組合物
BRPI0620460B8 (pt) 2005-12-22 2021-05-25 Glaxosmithkline Biologicals Sa uso de composição imunogênica para bebês, e, processo para produzir uma vacina
GB0607088D0 (en) 2006-04-07 2006-05-17 Glaxosmithkline Biolog Sa Vaccine
BRPI0813644B8 (pt) 2007-06-26 2021-05-25 Glaxosmithkline Biologicals Sa composição imunogênica, vacina, processo para fabricar a mesma, e, uso da composição imunogênica ou vacina
US20120164178A1 (en) 2008-04-16 2012-06-28 Ballou Jr William Ripley Vaccine
GB201003924D0 (en) 2010-03-09 2010-04-21 Glaxosmithkline Biolog Sa Immunogenic composition
SG194733A1 (en) 2011-05-17 2013-12-30 Glaxosmithkline Biolog Sa Vaccine against streptococcus pneumoniae
GB201518684D0 (en) 2015-10-21 2015-12-02 Glaxosmithkline Biolog Sa Vaccine
GB201711635D0 (en) 2017-07-19 2017-08-30 Glaxosmithkline Biologicals Sa Immunogenic composition

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6592876B1 (en) * 1993-04-20 2003-07-15 Uab Research Foundation Pneumococcal genes, portions thereof, expression products therefrom, and uses of such genes, portions and products
EP0912608B1 (fr) * 1996-05-01 2006-04-19 The Rockefeller University Proteines fixant la choline pour vaccins anti-pneumococciiques
CA2271720A1 (fr) * 1996-10-31 1998-05-07 Human Genome Sciences, Inc. Polynucleotides et sequences de streptococcus pneumoniae
CA2269636A1 (fr) * 1996-11-12 1998-05-22 The Regents Of The University Of Minnesota Proteine de liaison c3 de streptococcus pneumoniae
US6858706B2 (en) * 1998-04-07 2005-02-22 St. Jude Children's Research Hospital Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
EP1067962B1 (fr) * 1998-04-07 2010-03-24 MedImmune, LLC Derives de proteines pneumococciques de liaison de choline destines a des vaccins

Also Published As

Publication number Publication date
JP4739521B2 (ja) 2011-08-03
PL193132B1 (pl) 2007-01-31
TR200003498T2 (tr) 2001-10-22
JP2002516662A (ja) 2002-06-11
KR20010052244A (ko) 2001-06-25
WO1999051188A2 (fr) 1999-10-14
HUP0102306A1 (hu) 2001-09-28
CN1191851C (zh) 2005-03-09
AU3479699A (en) 1999-10-25
NZ507983A (en) 2004-03-26
WO1999051188A9 (fr) 2000-10-12
IL138939A0 (en) 2001-11-25
KR100638503B1 (ko) 2006-10-26
CA2326388A1 (fr) 1999-10-14
MXPA00009899A (es) 2002-05-08
AU3479799A (en) 1999-10-25
BR9909910A (pt) 2002-01-15
HUP0102306A3 (en) 2008-04-28
WO1999051188A3 (fr) 2001-04-19
CN1342088A (zh) 2002-03-27
NO20005081L (no) 2000-12-06
NO20005081D0 (no) 2000-10-09
AU764811B2 (en) 2003-08-28
PL347946A1 (en) 2002-04-22

Similar Documents

Publication Publication Date Title
US10632183B2 (en) Methods and compositions employing immunogenic fusion proteins
EP1810978B1 (fr) Acides nucléiques polypeptides à streptocoques de groupe B et composition thérapeutique et vaccins correspondants
US9249199B2 (en) Synthetic Streptococcus pneumoniae vaccine
US6858706B2 (en) Polypeptide comprising the amino acid of an N-terminal choline binding protein a truncate, vaccine derived therefrom and uses thereof
US8529912B2 (en) Group B Streptococcus polypeptides, nucleic acids and therapeutic compositions and vaccines thereof
US6495139B2 (en) Identification and characterization of novel pneumococcal choline binding protein, CBPG, and diagnostic and therapeutic uses thereof
AU764811B2 (en) A polypeptide comprising the amino acid of an n-terminal choline binding protein A truncate, vaccine derived therefrom and uses thereof
WO2000029434A2 (fr) IDENTIFICATION ET CARACTERISATION DE NOUVELLES PROTEINES PNEUMOCOCCIQUES SE LIANT A LA CHOLINE, CbpG AND CbpD, ET UTILISATIONS DIAGNOSTIQUES ET THERAPEUTIQUES CORRESPONDANTES
WO1999064610A1 (fr) Zmpb, nouveau determinant de la virulence de streptococcus pneumoniae, vaccin obtenu a partir de celui-ci et utilisations de ceux-ci
CZ20003803A3 (cs) Izolovaný polypeptid, izolovaný analog polypeptidu, izolovaný imunogenní polypeptid, izolovaná nukleová kyselina, vektor, hostitelský vektorový systém, protilátka, farmaceutický prostředek, způsob vyvolání imunitní odpovědi, způsob zabránění infekce, vakcína a způsob léčení

Legal Events

Date Code Title Description
FZDC Discontinued application reinstated
EEER Examination request
MKLA Lapsed

Effective date: 20180409